These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17031649)

  • 1. DNA vaccines for HIV: challenges and opportunities.
    Hokey DA; Weiner DB
    Springer Semin Immunopathol; 2006 Nov; 28(3):267-79. PubMed ID: 17031649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?
    Sutter G; Haas J
    AIDS; 2001; 15 Suppl 5():S139-45. PubMed ID: 11816162
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials.
    Rezaei T; Khalili S; Baradaran B; Mosafer J; Rezaei S; Mokhtarzadeh A; de la Guardia M
    J Control Release; 2019 Dec; 316():116-137. PubMed ID: 31669566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic and prophylactic DNA vaccines for HIV-1.
    Ramirez LA; Arango T; Boyer J
    Expert Opin Biol Ther; 2013 Apr; 13(4):563-73. PubMed ID: 23477730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug evaluation: DNA/MVA prime-boost HIV vaccine.
    Kent S; De Rose R; Rollman E
    Curr Opin Investig Drugs; 2007 Feb; 8(2):159-67. PubMed ID: 17328232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and opportunities for development of an AIDS vaccine.
    Nabel GJ
    Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards an HIV-1 subtype C vaccine.
    Nkolola JP; Essex M
    Vaccine; 2006 Jan; 24(4):391-401. PubMed ID: 16139396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV-1 vaccination--is there hope?].
    Speck RF; Brander C; Kündig TM
    Ther Umsch; 2005 Oct; 62(10):695-702. PubMed ID: 16277037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies.
    Chin'ombe N; Ruhanya V
    Pan Afr Med J; 2015; 20():386. PubMed ID: 26185576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological approaches for HIV therapy.
    Lori F; Kelly LM; Lisziewicz J
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):171-8. PubMed ID: 12769793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HIV vaccine: how and when?
    Esparza J
    Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.
    Ellenberger D; Otten RA; Li B; Aidoo M; Rodriguez IV; Sariol CA; Martinez M; Monsour M; Wyatt L; Hudgens MG; Kraiselburd E; Moss B; Robinson H; Folks T; Butera S
    Virology; 2006 Aug; 352(1):216-25. PubMed ID: 16725169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015.
    Weniger BG; Anglin IE; Tong T; Pensiero M; Pullen JK;
    Vaccine; 2018 Jan; 36(4):427-437. PubMed ID: 29174315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.
    Excler JL; Parks CL; Ackland J; Rees H; Gust ID; Koff WC
    Biologicals; 2010 Jul; 38(4):511-21. PubMed ID: 20537552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Designing an effective AIDS vaccine: strategies and current status].
    Coutsinos Z; Absi Z; Henin Y; Guillet JG; Launay O
    Rev Med Interne; 2008 Aug; 29(8):632-41. PubMed ID: 18258341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward an HIV vaccine.
    Letvin NL
    Annu Rev Med; 2005; 56():213-23. PubMed ID: 15660510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.